116 related articles for article (PubMed ID: 7887023)
1. Protection of rhesus macaques from SIV infection by immunization with different experimental SIV vaccines.
de Vries P; Heeney JL; Boes J; Dings ME; Hulskotte EG; Dubbes R; Koornstra W; ten Haaft P; Akerblom L; Eriksson S
Vaccine; 1994 Nov; 12(15):1443-52. PubMed ID: 7887023
[TBL] [Abstract][Full Text] [Related]
2. Comparison of protection afforded by whole virus ISCOM versus MDP adjuvanted formalin-inactivated SIV vaccines from IV cell-free or cell-associated homologous challenge.
Osterhaus A; de Vries P; Morein B; Akerblom L; Heeney J
AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1507-10. PubMed ID: 1466991
[TBL] [Abstract][Full Text] [Related]
3. Comparison of protection from homologous cell-free vs cell-associated SIV challenge afforded by inactivated whole SIV vaccines.
Heeney JL; de Vries P; Dubbes R; Koornstra W; Niphuis H; ten Haaft P; Boes J; Dings ME; Morein B; Osterhaus AD
J Med Primatol; 1992; 21(2-3):126-30. PubMed ID: 1433263
[TBL] [Abstract][Full Text] [Related]
4. Protection from pathogenic SIVmac challenge following short-term infection with a nef-deficient attenuated virus.
Norley S; Beer B; Binninger-Schinzel D; Cosma C; Kurth R
Virology; 1996 May; 219(1):195-205. PubMed ID: 8623530
[TBL] [Abstract][Full Text] [Related]
5. Simian immunodeficiency virus (SIV) gp130 oligomers protect rhesus macaques (Macaca mulatta) against the infection with SIVmac32H grown on T-cells or derived ex vivo.
Luke W; Coulibaly C; Dittmer U; Voss G; Oesterle R; Makoschey B; Sauermann U; Jurkiewicz E; Stahl-Henning C; Petry H; Hunsmann G
Virology; 1996 Feb; 216(2):444-50. PubMed ID: 8607276
[TBL] [Abstract][Full Text] [Related]
6. Protection of monkeys by a split vaccine against SIVmac depends upon biological properties of the challenge virus.
Stahl-Hennig C; Voss G; Dittmer U; Coulibaly C; Petry H; Makoschey B; Cranage MP; Aubertin AM; Lüke W; Hunsmann G
AIDS; 1993 Jun; 7(6):787-95. PubMed ID: 8363756
[TBL] [Abstract][Full Text] [Related]
7. Targeted lymph-node immunization with whole inactivated simian immunodeficiency virus (SIV) or envelope and core subunit antigen vaccines does not reliably protect rhesus macaques from vaginal challenge with SIVmac251.
Lü X; Kiyono H; Lu D; Kawabata S; Torten J; Srinivasan S; Dailey PJ; McGhee JR; Lehner T; Miller CJ
AIDS; 1998 Jan; 12(1):1-10. PubMed ID: 9456249
[TBL] [Abstract][Full Text] [Related]
8. Reduction of viral loads by multigenic DNA priming and adenovirus boosting in the SIVmac-macaque model.
Suh YS; Park KS; Sauermann U; Franz M; Norley S; Wilfingseder D; Stoiber H; Fagrouch Z; Heeney J; Hunsmann G; Stahl-Hennig C; Sung YC
Vaccine; 2006 Mar; 24(11):1811-20. PubMed ID: 16274888
[TBL] [Abstract][Full Text] [Related]
9. Vaccine protection of rhesus macaques against simian immunodeficiency virus infection.
Carlson JR; McGraw TP; Keddie E; Yee JL; Rosenthal A; Langlois AJ; Dickover R; Donovan R; Luciw PA; Jennings MB
AIDS Res Hum Retroviruses; 1990 Nov; 6(11):1239-46. PubMed ID: 2078406
[TBL] [Abstract][Full Text] [Related]
10. Vaccine protection against SIVmac infection by high- but not low-dose whole inactivated virus immunogen.
Hartung S; Norley SG; Ennen J; Cichutek K; Plesker R; Kurth R
J Acquir Immune Defic Syndr (1988); 1992; 5(5):461-8. PubMed ID: 1560342
[TBL] [Abstract][Full Text] [Related]
11. Improved protection of rhesus macaques against intrarectal simian immunodeficiency virus SIV(mac251) challenge by a replication-competent Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinant priming/gp120 boosting regimen.
Zhao J; Pinczewski J; Gómez-Román VR; Venzon D; Kalyanaraman VS; Markham PD; Aldrich K; Moake M; Montefiori DC; Lou Y; Pavlakis GN; Robert-Guroff M
J Virol; 2003 Aug; 77(15):8354-65. PubMed ID: 12857905
[TBL] [Abstract][Full Text] [Related]
12. Immunization with a live, attenuated simian immunodeficiency virus (SIV) prevents early disease but not infection in rhesus macaques challenged with pathogenic SIV.
Marthas ML; Sutjipto S; Higgins J; Lohman B; Torten J; Luciw PA; Marx PA; Pedersen NC
J Virol; 1990 Aug; 64(8):3694-700. PubMed ID: 2164591
[TBL] [Abstract][Full Text] [Related]
13. Passive immunization of macaques against SIV infection.
Gardner MB; Rosenthal A; Jennings M; Yee JA; Antipa L; MacKenzie M
J Med Primatol; 1994; 23(2-3):164-74. PubMed ID: 7966232
[TBL] [Abstract][Full Text] [Related]
14. Live attenuated simian immunodeficiency virus (SIV)mac in macaques can induce protection against mucosal infection with SIVsm.
Nilsson C; Mäkitalo B; Thorstensson R; Norley S; Binninger-Schinzel D; Cranage M; Rud E; Biberfeld G; Putkonen P
AIDS; 1998 Dec; 12(17):2261-70. PubMed ID: 9863867
[TBL] [Abstract][Full Text] [Related]
15. Immunization with virion-derived glycoprotein 130 from HIV-2 or SIV protects macaques against challenge virus grown in human or simian cells or prepared ex vivo.
Stahl-Hennig C; Coulibaly C; Petry H; Voss G; Dittmer U; Bodemer W; Makoschey B; Jurkiewicz E; Lüke W; Hunsmann G
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S27-32. PubMed ID: 7865316
[TBL] [Abstract][Full Text] [Related]
16. A single vaccination with attenuated SIVmac 239 via the tonsillar route confers partial protection against challenge with SIVmac 251 at a distant mucosal site, the rectum.
Stahl-Hennig C; Eisenblatter M; Franz M; Stoiber H; Tenner-Racz K; Suh YS; Jasny E; Falkensammer B; Ugucchioni M; Georgsson G; Baroni C; Dierich MP; Lifson JD; Steinman RM; Uberla K; Racz P; Ignatius R
Front Biosci; 2007 Jan; 12():2107-23. PubMed ID: 17127448
[TBL] [Abstract][Full Text] [Related]
17. Evolution of envelope-specific antibody responses in monkeys experimentally infected or immunized with simian immunodeficiency virus and its association with the development of protective immunity.
Cole KS; Rowles JL; Jagerski BA; Murphey-Corb M; Unangst T; Clements JE; Robinson J; Wyand MS; Desrosiers RC; Montelaro RC
J Virol; 1997 Jul; 71(7):5069-79. PubMed ID: 9188572
[TBL] [Abstract][Full Text] [Related]
18. Durable protection of rhesus macaques immunized with a replicating adenovirus-SIV multigene prime/protein boost vaccine regimen against a second SIVmac251 rectal challenge: role of SIV-specific CD8+ T cell responses.
Malkevitch NV; Patterson LJ; Aldrich MK; Wu Y; Venzon D; Florese RH; Kalyanaraman VS; Pal R; Lee EM; Zhao J; Cristillo A; Robert-Guroff M
Virology; 2006 Sep; 353(1):83-98. PubMed ID: 16814356
[TBL] [Abstract][Full Text] [Related]
19. Analysis of Complement-Mediated Lysis of Simian Immunodeficiency Virus (SIV) and SIV-Infected Cells Reveals Sex Differences in Vaccine-Induced Immune Responses in Rhesus Macaques.
Miller-Novak LK; Das J; Musich TA; Demberg T; Weiner JA; Venzon DJ; Mohanram V; Vargas-Inchaustegui DA; Tuero I; Ackerman ME; Alter G; Robert-Guroff M
J Virol; 2018 Oct; 92(19):. PubMed ID: 30021899
[TBL] [Abstract][Full Text] [Related]
20. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.
Kasturi SP; Kozlowski PA; Nakaya HI; Burger MC; Russo P; Pham M; Kovalenkov Y; Silveira ELV; Havenar-Daughton C; Burton SL; Kilgore KM; Johnson MJ; Nabi R; Legere T; Sher ZJ; Chen X; Amara RR; Hunter E; Bosinger SE; Spearman P; Crotty S; Villinger F; Derdeyn CA; Wrammert J; Pulendran B
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]